IL17A and type 1 diabetes mellitus: The NOD mouse model has been pivotal in demonstrating IL-17’s pathogenic role in T1D, where elevated IL-17/IL-17F expression in Langerhans islets correlates with insulitis progression and IL-17-deficient NOD mice showed delayed onset of T1D and reduced insulin inflammation [30].